Synmosa Biopharma Corporation (4114)
TWSE
Closed
Aug 26, 2026
Day's Range
29.8052 wk Range
27.55Profile - 4114 - Synmosa Biopharma Corporation
Profile
Mic Code
XTAI
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
0
Synmosa Biopharma Corporation is a specialty pharmaceutical company headquartered in Taiwan, recognized for its comprehensive involvement in the healthcare sector. The company specializes in the research, development, manufacturing, and distribution of a wide array of pharmaceutical products, including prescription medicines, over-the-counter drugs, active pharmaceutical ingredients, medical devices, cosmetics, and chemical food additives. It plays a pivotal role in areas such as cardiovascular, respiratory, sex hormones, urology, and oncology therapies, providing essential solutions for both acute and chronic conditions. Synmosa also manufactures and markets environmental drugs and health-related products, supporting both human and animal health. Its product portfolio is built on advanced technology platforms including effervescent tablets, nasal sprays, metered dose inhalers, hormones, and granules, underlining its innovative capacity in drug delivery and formulation. With five GMP-certified manufacturing facilities and a strong footprint not only in Taiwan but also across markets in Asia, the Middle East, Africa, and Latin America, Synmosa Biopharma Corporation stands as one of the leading forces driving pharmaceutical standards and healthcare advancement in the region.
Profile Details
Type
Common Stock
Address
No. 396 Neihu Road
City
Taipei
Zip
114
Country
Taiwan
Phone
886 2 8797 7100
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
